Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-007054)

Filing Details

Accession Number:: 0001181431-13-007054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-06 10:17:00
Reporting Period:: 2013-02-04

Filing Date:: 2013-02-06
Accepted Time:: 2013-02-06 10:17:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722104	Savient Pharmaceuticals Inc	SVNT	Medicinal Chemicals & Botanical Products (2833)	133033811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250318	K Philip Yachmetz	Savient Pharmaceuticals, Inc. 400 Crossing Blvd. Bridgewater NJ 08807	Svp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $.01 Par Value Per Share	Disposition	2013-02-04	27,297	$1.01	306,904	No	4	S	Direct
Common Stock $.01 Par Value Per Share	Disposition	2013-02-04	3,203	$1.02	303,701	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012 and February 27, 2012.